NCT07653880

Brief Summary

This randomized controlled, single-blind clinical trial investigates whether virtual reality (VR)-assisted, video game-based exercise training, added to a conventional pulmonary physiotherapy and rehabilitation program, improves functional level, respiratory parameters, and physical fitness in pediatric patients (5-18 years) following hematopoietic stem cell transplantation (HSCT). Participants attended 24 supervised, face-to-face exercise sessions over 8 weeks (3×/week) under physiotherapist supervision. The Experimental Group received game-based exercise using the Nintendo Wii Fit U platform with the Wii Balance Board and the Breathing Labs Breathing Games software (Slovenia) in addition to the conventional program. Outcomes included the Modified Alpha-Fit Pediatric Test Battery (vertical jump, 6-minute walk test, sit-and-reach, flamingo balance), upper-extremity isometric muscle strength (handheld dynamometry) and handgrip strength (Jamar), pulmonary function tests, maximal inspiratory and expiratory mouth pressures, accessory respiratory muscle architecture by myotonometry (MyotonPro: sternocleidomastoid, upper trapezius, pectoralis major), and ultrasound assessment of pleural thickness, diaphragm thickness, and diaphragm excursion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 16, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 17, 2026

Completed
Last Updated

June 17, 2026

Status Verified

June 1, 2026

Enrollment Period

8 months

First QC Date

April 29, 2026

Last Update Submit

June 16, 2026

Conditions

Keywords

Hematopoietic Stem Cell Transplantation (HSCT)Pediatric PhysiotherapyPulmonary RehabilitationExergamingPhysiotherapy and Rehabilitation

Outcome Measures

Primary Outcomes (2)

  • Vertical Jump Test

    Component of the Modified Alpha-Fit Pediatric Test Battery. Participant first reaches the maximum standing-reach height with one arm, then jumps vertically to the maximum reachable height; the difference between the two marks is recorded in centimeters. The best of two trials is retained. Higher values indicate greater lower-extremity power. Safety Issue: No.

    Baseline to Week 8

  • Diaphragm Ultrasound

    Right-hemidiaphragm thickness measured at end-expiration in the 9th intercostal space (anterior axillary line) using B-mode ultrasonography with a 7 MHz transducer (Toshiba Aplio XG, Tokyo, Japan). Right-hemidiaphragm excursion measured by M-mode with a 3.5 MHz curved-array transducer during quiet breathing, deep breathing, and sniff testing. Mean of three respiratory cycles reported in millimeters. Left hemidiaphragm not assessed due to image-quality limitations.

    Baseline to Week 8

Secondary Outcomes (9)

  • Six-Minute Walk Test

    Baseline to Week 8

  • Sit-and-Reach Test

    Baseline to Week 8

  • Flamingo Balance Test

    Baseline to Week 8

  • Upper-Extremity Isometric Muscle Strength

    Baseline to Week 8

  • Handgrip Strength

    Baseline to Week 8

  • +4 more secondary outcomes

Study Arms (2)

Arm 1 - Active Comparator: Control Group (CG)

ACTIVE COMPARATOR

Conventional pulmonary physiotherapy and rehabilitation program delivered as 24 supervised face-to-face sessions across 8 weeks (3×/week) under physiotherapist supervision. Each session lasted 25 minutes and included diaphragmatic breathing, thoracic expansion exercises (chest and bilateral segmental), incentive spirometry (Triflo® or Voldyne®), postural drainage and percussion, cough technique training, breathing control, and range-of-motion exercises (2 sets × 5 repetitions with 5-6 tidal-breath rest). Intensity targeted Modified Borg Scale 4-6.

Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION

Arm 2 - Experimental: VR-Assisted Game-Based Exercise + Conventional Physiotherapy (EG)

EXPERIMENTAL

Identical conventional pulmonary physiotherapy program PLUS virtual reality-assisted, video game-based exercise delivered concurrently in 24 supervised face-to-face sessions across 8 weeks (3×/week). Game-based component combined the Breathing Labs Breathing Games (5 games with progressive difficulty) and Nintendo Wii Fit U with the Wii Balance Board (8 balance/mobility games; 4 played per session at 5 minutes each). Intensity titrated by Modified Borg Scale (target 4-6).

Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION

Interventions

Physiotherapist-led pulmonary rehabilitation program (24 sessions; 3×/week × 8 weeks). Components: diaphragmatic breathing, thoracic expansion exercises, incentive spirometry, postural drainage with percussion, cough techniques, breathing control, and range-of-motion exercises. Intensity titrated by Modified Borg Scale (target 4-6).

Arm 1 - Active Comparator: Control Group (CG)Arm 2 - Experimental: VR-Assisted Game-Based Exercise + Conventional Physiotherapy (EG)

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Currently receiving care in a pediatric bone marrow transplantation unit (post-HSCT).
  • Age between 5 and 18 years (inclusive).
  • Able to perform pursed-lip breathing with expiration ≥ 3 seconds.
  • Ambulatory and able to cooperate with verbal instructions.
  • Clinically stable as confirmed by the treating physician at the time of enrollment.
  • No history of orthopedic, neurological, or cardiac disease.

You may not qualify if:

  • Facial palsy.
  • Severe visual impairment or visual field defects.
  • Aphasia.
  • History of abdominal or thoracic surgery.
  • During study: medically unstable status; new diagnosis of cutaneous graft-versus-host disease (GvHD) requiring high-dose steroid therapy; respiratory-tract or systemic infection requiring isolation; new psychiatric illness with poor prognosis; relocation precluding follow-up; withdrawal of consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istinye University

Istanbul, 34010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neoplasms

Interventions

ExerciseDosage Forms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaPharmaceutical PreparationsTechnology, PharmaceuticalInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcomes assessor was blinded to group allocation. Participants and treating physiotherapists were not blinded due to the nature of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment Randomized Controlled Single-Blind Trial with parallel allocation; stratified by gender.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor; PhD

Study Record Dates

First Submitted

April 29, 2026

First Posted

June 17, 2026

Study Start

January 16, 2025

Primary Completion

August 30, 2025

Study Completion

September 15, 2025

Last Updated

June 17, 2026

Record last verified: 2026-06

Locations